Navigation Links
New regulatory mechanism discovered for cell identify and behavior in forming organs
Date:10/31/2008

The Wnt signaling pathway is a complex network of proteins best known for their role in stimlating cell behavior during embryo development and in cancer. They also are involved in normal physiological processes in adult animals. Parts of the Wnt pathway have been conserved between species during the long course of evolution, all the way from simple roundworms to humans.

Previous research in Xenopus has established that a low level of activity from a molecule called B-catenin which promotes cell-to-cell adhesion and is part of the Wnt pathway is necessary to maintain accurate foregut formation and initiate liver and pancreas development. Unknown before the study by Dr. Zorn's team was which Wnt genes are involved and how Wnt and B-catenin activity are regulated along the frog's developing anterior-posterior body axis.

During the very early phases of embryo development when the organism is still essentially flattened layers of cells called an endoderm Dr. Zorn's team found Wnt's stimulation of B-catenin must be restricted in the anterior region so the tissue of forming foregut organs maintain its integrity. Their experiments showed that Sfrp5 steps in at the right time and place to repress Wnt signaling, allowing the cells to form an epithelial sheet, or lining an essential step in organ development.

In one experiment, when researchers removed the Sfrp5 protein, the resulting Sfrp5-depleted Xenopus embryos had smaller foregut cavities filled with unorganized early-stage endoderm cells, which were incapable of properly forming liver and pancreatic organs.

Dr. Zorn and colleagues said their results have possible implications in metastatic cancer. For one, Sfrp proteins are already known to be tumor suppressors that are genetically inactivated in some cancers as they progress to aggressive carcinomas. Carcinomas typically originate in epithelial cells which form linings surrounding the surfaces and cavities of many body st
'/>"/>

Contact: Nick Miller
nicholas.miller@cchmc.org
513-803-6035
Cincinnati Children's Hospital Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Use of nanomaterials in food packaging poses regulatory challenges
2. Type 1 diabetes triggered by lazy regulatory T-cells: McGill researchers
3. Corn researchers discover novel gene shut-off mechanisms
4. New cell division mechanism discovered
5. Scientists unveil mechanism for up and down in plants
6. Newly-discovered mechanism can explain the Beckwith-Wiedemann syndrome
7. Rong Li Lab probes mechanism of asymmetry in meiotic cell division
8. Conaway Lab identifies novel mechanism for regulation of gene expression
9. New mechanism for cardiac arrhythmia discovered
10. Novel anti-cancer mechanism found in long-lived rodents
11. Oxidative stress: Mechanism of cell death clarified

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...pings of gravy and dessert at the holiday table ar...ously thought. According to a new research report ... http://www.fasebj.org ), a diet that is high in f...timately cause our bodies to store too much fat. T... as the already difficult task of converting high-...
(Date:11/30/2009)...s available in German . , The DFG has appro...arch Centres as of 1 January 2010. This decision w...in Bonn. The new centres will initially be funded ...ition, 20 percent overhead funding for indirect co...ntres, research topics range from modern prosthese...
(Date:11/30/2009)...- The inaugural Global Conference on Systems & Ent... Washington, DC, focuses on the convergence of com...al importance to society. , The goal of the ...ivity around targeted complex systems, examined by...includes Critical Infrastructure Systems, includin...
Breaking Biology News(10 mins):Happy holidays from the groaning board; Western diets turn on fat genes 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Finesse Solutions Expands Into State of the Art Facility in San Jose CA USA 12606 1Aussie and Kiwi researchers make double MS genetic discovery 8821 1Aussie and Kiwi researchers make double MS genetic discovery 8821 2Symbia net Hotspot for Remote Access 48825 1Symbia net Hotspot for Remote Access 48825 2Symbia net Hotspot for Remote Access 48825 3
...sts from around the world will convene at the Univ... key findings from the most ambitious effort ever ...tants in the Arctic and determine how they contrib...way in the vast, climate-sensitive region. , The ...ARCAT was conducted most intensively during two th...
...ands, May 26, 2009 There are several risk factors...scular dementia. Based on an increasing number of ...deficiency, an article in the current issue of the...lliam B. Grant, PhD of the Sunlight, Nutrition, an...rther investigation of possible direct or indirect...
...sen sharply in developed countries in the wake of ...Europeans live with the condition. Foot problems a...for diabetics, who are at risk of serious complica...lood supply to their feet. Both conditions can lea... they get infected and become gangrenous, can lead...
Other Biology News:Spring agricultural fires have large impact on melting Arctic 2Spring agricultural fires have large impact on melting Arctic 3Is vitamin D deficiency linked to Alzheimer's disease and vascular dementia? 2Protective footwear for diabetics at a high-street price 2Protective footwear for diabetics at a high-street price 3
(Date:12/1/2009)...nc. today announced a collaborative research agree... at evaluating EpiVax’s proprietary Tregitop...mental immune responses to certain drugs. In the c...x Tregitope technology will be evaluated for its e...ics. , (Vocus) December 2...
(Date:12/1/2009).... 1 Aethlon Medical, Inc...it will present at the LD MICRO Conference on Thur...uxe Hotel in Los Angeles. Aethlon Medical,s Chairm...te overview and will provide an update on the comp...Hemopurifier®, a first-in-class artificial ad...
(Date:12/1/2009)...na, Dec. 1 /PRNewswire-Asia-FirstCall/ -- China Sk...he Company") (Nasdaq: CSKI ), a leading,fully int...ucing,over-the-counter drugs in the People,s Repub...pany has engaged Guangdong Mediacy Kind Medical De... its exclusive sales agent for the,Company,s AMI D...
(Date:12/1/2009)...wswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bull...d, biopharmaceutical company developing human vacc...iciency Virus) and other infectious agents, today ...oday is the 21st World AIDS Day and as we remember...HIV/AIDS pandemic, we remain focused and devoted t...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6
... Calif., Oct. 29 Sangamo,BioSciences, Inc. (Nasda...cial results and accomplishments., For the third ... a,consolidated net loss of $6.3 million, or $0.15..., or $0.11 per share, for the same period in 2007....ash equivalents and,investments of $59.5 million. ...
...Mass., Oct. 29 Aware, Inc. (Nasdaq:,AWRE), a lead...s software,announced today that its Board of Direc...inally authorized on August 28, 2007 to repurchase...o $5 million worth of shares of,the Company,s comm...cember,31, 2009 at prevailing market prices. The B...
...lion Net Revenues, $0.10 Net Income Per Share, SA...ies, Inc. (Nasdaq: VNUS ), a leading provider of ...nt of venous disease, today announced its,financia..., 2008., Net revenues for the third quarter of 20...7.5 million for the third quarter of 2007. Net,rev...
Other Biology Technology:Sangamo BioSciences Reports Third Quarter 2008 Financial Results 2Sangamo BioSciences Reports Third Quarter 2008 Financial Results 3Sangamo BioSciences Reports Third Quarter 2008 Financial Results 4Sangamo BioSciences Reports Third Quarter 2008 Financial Results 5Sangamo BioSciences Reports Third Quarter 2008 Financial Results 6Sangamo BioSciences Reports Third Quarter 2008 Financial Results 7Aware, Inc. Announces Extension of Stock Repurchase Plan 2VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 2VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 3VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 4VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 5VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 6VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 7VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 8VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 9VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 10
Amido Black 10B, CI 20470 from Research Organics, Inc.
Anti-Taste Receptor 2 (TR2) Polyclonal Antibody, Unconjugated from CHEMICON
Mouse Anti-Yersinia pestis Monoclonal Antibody, Unconjugated, Clone YPF19 from GeneTex
Anti-Human Ig Lambda-chain Monoclonal Antibody, Unconjugated, Clone ICO-16 from Cell Sciences
Biology Products: